Transmission of resistant HIV common in clusters of newly infected individuals

This article is more than 15 years old. Click here for more recent articles on this topic

Swiss researchers have found that 84% of individuals with newly-diagnosed HIV who were infected with a strain of the virus resistant to antiretroviral drugs were part of transmission clusters composed only of other newly diagnosed individuals. The study, which is published in the online edition of AIDS also found that 9% of recently diagnosed individuals were infected with a drug-resistant strain of HIV, and that 53% of individuals with recent HIV infection could be linked to a transmission cluster.

“Newly diagnosed, untreated individuals are a significant source of resistant strains, thus suggesting an important self-fueling mechanism for transmitted drug resistance”, write the investigators.

HIV transmission chains are poorly defined and documented. Mounting evidence from studies using phylogenetics analysis suggests that individually recently infected with HIV play an important part in the spread of the virus. Transmission clusters have been identified that are composed of recently-infected individuals.

Glossary

transmission cluster

By comparing the genetic sequence of the virus in different individuals, scientists can identify viruses that are closely related. A transmission cluster is a group of people who have similar strains of the virus, which suggests (but does not prove) HIV transmission between those individuals.

strain

A variant characterised by a specific genotype.

 

reverse transcriptase

A retroviral enzyme which converts genetic material from RNA into DNA, an essential step in the lifecycle of HIV. Several classes of anti-HIV drugs interfere with this stage of HIV’s life cycle: nucleoside reverse transcriptase inhibitors and nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). 

nucleoside

A precursor to a building block of DNA or RNA. Nucleosides must be chemically changed into nucleotides before they can be used to make DNA or RNA. 

drug resistance

A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs because of an accumulation of HIV mutations in its genotype. Resistance can be the result of a poor adherence to treatment or of transmission of an already resistant virus.

However, the impact of transmission clusters in the frequency of transmitted drug resistant HIV has not been fully evaluated. Swiss investigators analysed viral sequences obtained from all individuals newly diagnosed with HIV in Geneva between 2000 and 2008.

Samples from 637 individuals were included in the investigators’ analysis. Resistance to anti-HIV drugs was present in 54 patients (9%).

Individuals with resistance were more likely to be male (79% vs. 63%, p = 0.02), older (38 vs. 34 years, p = 0.001), have a higher CD4 cell count (452 cells/mm3 vs. 339 cells/mm3, p = 0.02), and a lower viral load (40,000 copies/ml vs. 75,000 copies/ml, p = 0.02).

The overall rate of transmitted resistance increased significantly over the eight year period of the study (p = 0.015). This was entirely due to an increase in transmitted non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance (p = 0.002).

Phylogentic analysis showed that 222 (35%) of the newly diagnosed individuals were part of 105 transmission clusters.

Clusters were more frequent in those recently infected with HIV than those whose HIV infection was of unknown duration (53% vs. 30%, p

Of the 222 newly diagnosed individuals in transmission clusters, 147 (66%) were in clusters composed entirely of newly diagnosed individuals.

Newly diagnosed individuals with drug-resistant virus were significantly more likely to be part of a transmission cluster than individuals with drug-sensitive virus (59% vs. 33%, p

Of the 32 recently diagnosed individuals with transmitted resistance, 27 (84%) were part of transmission clusters composed of recently-infected individuals.

Consistent with these findings, the prevalence of transmitted resistance was higher in individuals who were part of clusters than those who were not (14% vs. 5%, p

“Our findings highlight the role of newly diagnosed individuals, not yet exposed to antiretroviral drugs, in replenishing the pool of individuals infected with drug-resistant HIV”, conclude the investigators.

References

Yerly S et al. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS 23 (online edition), 2009.